Form 4 for TVTX Travere Therapeutics, Inc.
Accepted 2022-02-11 00:00:00 ET · period of report 2022-02-10 · accession 0001209191-22-008818 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-02-11 | 2022-02-10 | TVTX | Dube Eric M | CEO, Dir | S - Sale | $27.84 | -4,832 | 159.9K | -3% | -$134.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-10 | S | D | 4,832 | $27.84 | 159,913 | D | — | — |